Tag:
Ilypsa
Latest Headlines
Latest Headlines
Amgen inks $420M deal to buy Ilypsa
With analysts turning critical over a questionable pipeline, Amgen has agreed to pay $420 million to snap up Ilypsa, a private biotech that's been developing a new therapy for kidney disease.
